GPT and leukemia: The results obtained in this study showed that receiving oral silymarin in a 9-month treatment period leads to a slight significant decrease in serum levels of AST, ALT, bilirubin, and GGT in children with leukemia, but no significant effect was observed on cholesterol or albumin.